Rheumatology International 1983-01-01

A comparison of the effects of two gold-containing therapeutic agents on articular chondrocyte growth in vitro.

C J Kirkpatrick, W Mohr

Index: Rheumatol. Int. 3(2) , 49-56, (1983)

Full Text: HTML

Abstract

Chondrocyte structure and function under the influence of two gold-containing therapeutic agents, aurothioglucose and triethylphosphine gold, were studied in a monolayer culture system for cultivating lapine articular chondrocytes. The functional parameters investigated were chondrocyte proliferation and the incorporation of 35SO4 as indicator of glycosaminoglycan synthesis. Aurothioglucose (0.2, 1 and 10 micrograms/ml) failed to affect either parameter and caused no cytotoxic effect detectable with the light microscope. Triethylphosphine gold (1.5 and 3 micrograms/ml) prevented subcultured chondrocytes from forming monolayers and was cytotoxic to chondrocytes present in established monolayers, studied with the light and scanning electron microscope. A 0.3 microgram/ml concentration did not alter chondrocyte proliferation or sulphate incorporation and was not cytotoxic.


Related Compounds

Related Articles:

Synthesis of thionato(triethylphosphine) gold(I) complexes:analogues of "auranofin," an antiarthritic drug.

1990-02-01

[J. Inorg. Biochem. 38(2) , 95-100, (1990)]

Inhibition of human phospholipase C by aurothiomalate and (triethylphosphine) gold complexes.

1992-03-01

[Arzneimittelforschung 42(3) , 328-33, (1992)]

The structural flexibility of ferric cytochrome c: regulation of the spin-state equilibrium by an anti-arthritic gold(I) compound at neutral pH.

1980-07-28

[FEBS Lett. 116(2) , 227-30, (1980)]

31P nuclear-magnetic-resonance studies at 24 and 162 MHz of blood containing an anti-arthritic gold phosphine: relaxation via chemical-shift anisotropy.

1980-10-01

[Biochem. Soc. Trans. 8(5) , 635-6, (1980)]

Inhibition of human neutrophil collagenase by gold(I) salts used in chrysotherapy.

1987-04-14

[Biochem. Biophys. Res. Commun. 144(1) , 101-8, (1987)]

More Articles...